Pharmaceutical, medical and veterinary preparations; medical, veterinary, diagnostic and pharmaceutical preparations and materials; reagents (medical); chemical reagents (medical); medical, veterinary, clinical, diagnostic and pharmaceutical reagents, agents, chemicals, materials, substances and preparations; medical, clinical, diagnostic and pharmaceutical reagents, agents, chemicals, materials, substances and preparations for medical and veterinary use; optimised aptamer molecules for medical and veterinary use; medical and veterinary diagnostic reagents and assays for testing of body fluids; medical and veterinary diagnostic test strips; diagnostic biomarker reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic or treatment purposes; nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes; nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes; diagnostic testing kits (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); diagnostic reagents for medical and veterinary use for sale in kit form; diagnostic kits comprising specimen receptors and reagents for medical, veterinary and diagnostic testing; medical and veterinary diagnostic reagents and assays for testing of fluids.;
Research and development services (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); design and development of diagnostic apparatus, instruments, equipment, tools and devices; research, design and development in the field of diagnostic preparations; research, design and development of reagents; research, design and development of aptamer reagents; research, design and development of aptamer reagents for integration into diagnostic platforms; research, design and development of reagents for therapeutic applications; research, design and development of aptamer reagents for therapeutic applications; custom development of reagents; custom development of aptamer reagents; optimisation of aptamer molecules (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); research, design and development of nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes; research, design and development of nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes laboratory testing services; laboratory services for analytical testing; design and development of testing and analysis methods; preparation of biological samples for testing and analysis in research laboratories; medical and veterinary research services; medical and veterinary laboratory services; scientific research and investigations for medical and veterinary purposes; analysis of human and animal tissues and samples for medical and veterinary research; biological research, clinical research, medical research and veterinary research; provision of information and data relating to medical and veterinary research and development; information and advisory services in respect of the aforementioned services.;
Medical, veterinary and diagnostic services; medical and veterinary testing services; medical and veterinary testing for diagnostic or treatment purposes; medical and veterinary analysis services for diagnostic and treatment purposes; medical and veterinary testing services relating to diagnosis and treatment; medical and veterinary analysis services information and advisory services in respect of the aforementioned services.;